Prognostic feature based on androgen-responsive genes in bladder cancer and screening for potential targeted drugs.

Single-cell transcriptome-based multilayer network biomarker for predicting prognosis and therapeutic response of gliomas.

Differential regulatory network-based quantification and prioritization of key genes underlying cancer drug resistance based on time-course RNA-seq data.